AFA
GSK icon

Aurora Financial Advisors’s GSK GSK Stock Holding History

Aurora Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$267K Buy
+6,029
New +$279K 0.19% 155

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aurora Financial Advisors's GSK Position: Q4 2017 in Review

Aurora Financial Advisors opened a new position in GSK (GSK) in Q4 2017: 6,029 shares worth $267K. The stake represents 0.19% of the portfolio and ranks #155 among its holdings.

764 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

  • Aurora Financial Advisors held 6,029 shares of GSK worth $267K as of Q4 2017.
  • GSK was a new Aurora Financial Advisors position in Q4 2017.
  • GSK made up 0.19% of Aurora Financial Advisors's portfolio in Q4 2017, its #155 holding.
  • 764 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on Aurora Financial Advisors's 13F filing for Q4 2017, filed 16 Mar 2018.